Severe Combined Immunodeficiency Clinical Trial
Official title:
A Study of EZN-2279 (Polyethylene Glycol Recombinant Adenosine Deaminase [PEG-rADA]) Administered as a Weekly Intramuscular Injection in Patients With Adenosine Deaminase (ADA)-Deficient Combined Immunodeficiency
The purpose of this study is to evaluate the safety, efficacy, and pharmacokinetics of EZN-2279 in patients with ADA-deficient combined immunodeficiency currently being treated with Adagen.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00006335 -
Influences on Female Adolescents' Decisions Regarding Testing for Carrier Status of XSCID
|
N/A | |
Not yet recruiting |
NCT02231983 -
Clinical Characteristics and Genetic Profiles of Severe Combined Immunodeficiency in China
|
N/A | |
Active, not recruiting |
NCT03597594 -
Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID)
|
Phase 1/Phase 2 | |
Completed |
NCT00000603 -
Cord Blood Stem Cell Transplantation Study (COBLT)
|
Phase 2 | |
Completed |
NCT00001255 -
Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency: A Natural History Study
|
N/A | |
Recruiting |
NCT05651113 -
The Experience of Screening for SCID
|
||
Completed |
NCT00794508 -
MND-ADA Transduction of CD34+ Cells From Children With ADA-SCID
|
Phase 2 | |
Recruiting |
NCT03538899 -
Autologous Gene Therapy for Artemis-Deficient SCID
|
Phase 1/Phase 2 | |
Recruiting |
NCT05298930 -
Feasibility Study to Assess an Adapted Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Transplantation
|
N/A | |
Recruiting |
NCT01821781 -
Immune Disorder HSCT Protocol
|
Phase 2 | |
Completed |
NCT00845416 -
Newborn Screening for Severe Combined Immunodeficiency (SCID) in a High-Risk Population
|
N/A | |
Terminated |
NCT00006054 -
Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies
|
N/A | |
Completed |
NCT03878069 -
Registry Study of Revcovi Treatment in Patients With ADA-SCID
|
||
Recruiting |
NCT01019876 -
Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases
|
Phase 2/Phase 3 | |
Completed |
NCT03513328 -
Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation
|
Phase 1/Phase 2 | |
Withdrawn |
NCT02177760 -
Sirolimus Prophylaxis for aGVHD in TME SCID
|
Phase 2 | |
Recruiting |
NCT00695279 -
Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products
|
||
Terminated |
NCT02127892 -
SCID Bu/Flu/ATG Study With T Cell Depletion
|
Phase 1/Phase 2 | |
Completed |
NCT04246840 -
Study Through Imaging of Visceral Lymphoid Organs in Patients With SCID Who Have Recieved Bone Marrow Allograft
|
||
Completed |
NCT01529827 -
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
|
Phase 2 |